News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
149,736 Results
Type
Article (8537)
Company Profile (44)
Press Release (141152)
Multimedia
Podcasts (34)
Webinars (6)
Section
Business (46642)
Career Advice (94)
Deals (6571)
Drug Delivery (17)
Drug Development (25551)
Employer Resources (13)
FDA (3433)
Job Trends (3743)
News (74744)
Policy (4966)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Digital (1)
2027 Genetown Elite (2)
2027 Genetown Standard (2)
2027 NextGen (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (400)
Accelerated approval (31)
ADA (5)
Adcomms (16)
Allergies (19)
Alliances (12244)
ALS (47)
Alzheimer's disease (244)
Antibody-drug conjugate (ADC) (552)
Approvals (3788)
Artificial intelligence (323)
ASCO (338)
Autoimmune disease (163)
Automation (11)
Bankruptcy (56)
Belgium (10)
Best Places to Work (3413)
BIO (29)
Biologics (19)
BIOSECURE Act (1)
Biosimilars (149)
BioSpace Insights (27)
Biotechnology (36)
Bispecific (33)
Bladder cancer (183)
Brain cancer (72)
Breast cancer (714)
Cancer (5615)
Cardiovascular disease (58)
Career advice (93)
Career pathing (7)
CAR-T (198)
CDC (5)
CDMO (52)
Celiac Disease (1)
Cell therapy (401)
Cervical cancer (35)
Clinical research (23924)
Collaboration (1058)
Commercialization (16)
Company closure (2)
Compensation (348)
Complete response letters (25)
COVID-19 (494)
CRISPR (39)
CRO (1)
C-suite (557)
Cystic fibrosis (8)
Data (3936)
Decentralized trials (2)
Denatured (5)
Depression (11)
Dermatology (34)
Diabetes (74)
Diagnostics (2059)
Digital health (16)
Diversity (2)
Diversity, equity & inclusion (5)
Drug discovery (159)
Drug pricing (27)
Drug shortages (2)
Duchenne muscular dystrophy (46)
Earnings (16053)
Editorial (21)
Employer branding (2)
Employer resources (15)
ESMO (427)
Events (28521)
Executive appointments (427)
Eye disease (4)
FDA (4860)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (1)
Frontotemporal dementia (2)
Funding (526)
Gene editing (60)
Generative AI (32)
Gene therapy (126)
GLP-1 (157)
Government (565)
Guidances (106)
Healthcare (4543)
Hematology (110)
HIV (14)
Huntington's disease (4)
IgA nephropathy (22)
Immunology and inflammation (113)
Immuno-oncology (152)
Indications (135)
Infectious disease (566)
Inflammatory bowel disease (59)
Inflation Reduction Act (3)
Influenza (29)
Intellectual property (86)
Interviews (14)
IPO (3255)
IRA (8)
Job creations (505)
Job search strategy (75)
JPM (26)
Kidney cancer (29)
Kidney disease (9)
Labor market (13)
Layoffs (151)
Leadership (10)
Legal (520)
Licensing (39)
Liver cancer (64)
Longevity (8)
Lung cancer (857)
Lung diease (6)
Lymphoma (346)
Machine learning (28)
Management (4)
Manufacturing (254)
Marketing (11)
MASH (14)
Medical affairs (1)
Medical device (1065)
Medtech (1087)
Mergers & acquisitions (3698)
Metabolic disorders (189)
mRNA (117)
Multiple sclerosis (35)
Multispecific (1)
NASH (1)
Netherlands (1)
Neurodegenerative disease (61)
Neuropsychiatric disorders (11)
Neuroscience (509)
NextGen: Class of 2026 (1030)
Non-profit (576)
Now hiring (31)
Obesity (93)
Opinion (57)
Ovarian cancer (238)
Pain (40)
Pancreatic cancer (345)
Parkinson's disease (60)
Partnered (1)
Patents (161)
Patient advocacy (2)
Patient recruitment (310)
Patient selection (38)
Peanut (5)
People (14902)
Peptides (3)
Pharmaceutical (11)
Pharmacy benefit managers (4)
Phase 1 (9051)
Phase 2 (10087)
Phase 3 (7615)
Pipeline (4384)
Policy (54)
Postmarket research (493)
Preclinical (2879)
Press Release (2)
Prostate cancer (289)
Psychedelics (5)
Radioligand (2)
Radiopharmaceuticals (283)
Rare diseases (235)
Real estate (823)
Recruiting (7)
Regenerative medicine (1)
Regulatory (5767)
Reports (13)
Research institute (797)
Resumes & cover letters (11)
RNA editing (4)
RSV (13)
Schizophrenia (44)
Series A (91)
Series B (53)
Service/supplier (1)
Sickle cell disease (45)
Special edition (5)
Spinal muscular atrophy (17)
Sponsored (8)
Startups (842)
State (1)
Stem cells (1)
Stomach cancer (16)
Substance use disorders (1)
Supply chain (18)
Switzerland (2)
Tariffs (9)
The Weekly (28)
Vaccines (277)
Venture capital (58)
Weight loss (46)
Women's health (25)
Worklife (1)
Date
Today (50)
Last 7 days (207)
Last 30 days (939)
Last 365 days (9177)
2026 (7671)
2025 (8941)
2024 (10139)
2023 (11441)
2022 (14242)
2021 (14261)
2020 (12002)
2019 (9233)
2018 (6879)
2017 (7642)
2016 (6808)
2015 (7564)
2014 (4943)
2013 (3482)
2012 (3716)
2011 (3732)
2010 (3431)
Location
Africa (97)
Alabama (23)
Alaska (1)
Arizona (34)
Arkansas (3)
Asia (12507)
Australia (1738)
California (4817)
Canada (1120)
China (1017)
Colorado (136)
Connecticut (179)
Delaware (344)
Europe (23557)
Florida (701)
Georgia (23)
Idaho (7)
Illinois (523)
India (44)
Indiana (172)
Iowa (13)
Japan (365)
Kansas (11)
Kentucky (17)
Louisiana (4)
Maine (5)
Maryland (491)
Massachusetts (3642)
Michigan (45)
Minnesota (168)
Missouri (23)
Montana (12)
Nebraska (3)
Nevada (13)
New Hampshire (13)
New Jersey (1323)
New Mexico (5)
New York (1083)
North Carolina (322)
Northern California (2616)
Ohio (100)
Oklahoma (1)
Oregon (7)
Pennsylvania (750)
Puerto Rico (10)
Rhode Island (6)
South America (125)
South Carolina (9)
Southern California (1928)
Tennessee (63)
Texas (893)
United States (16044)
Utah (109)
Virginia (41)
Washington D.C. (9)
Washington State (440)
Wisconsin (63)
149,736 Results for "kineta immuno oncology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Immuno-oncology
Astellas bets up to $1.34B for option to advance Audax immuno-oncology asset
Astellas Pharma could secure the exclusive global rights to Audax Biosciences’ DAX-044, an antibody-cytokine fusion therapy that activates the immune system in the vicinity of the tumor.
October 28, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Solstice Oncology Launches with $225 Million Series A Financing to Advance Porustobart, a Neoadjuvant Immuno-Oncology Therapy
September 9, 2026
·
6 min read
Press Releases
New Publication Broadens the Potential of DiviTum TKa in Immuno-Oncology
August 25, 2026
·
2 min read
Press Releases
Immuno-Oncology Pioneer Dr. Michael Kalos Joins Kos Biotechnology Partners as Venture Partner
September 10, 2026
·
3 min read
Press Releases
Biovica Expands Japanese Patent Protection in Immuno-Oncology
July 16, 2026
·
2 min read
Press Releases
Biovica Granted Japanese Patent for Immuno-Oncology
July 1, 2026
·
2 min read
Press Releases
Harbour BioMed Partner, Solstice Oncology, announces $225 Million Series A Financing to Advance Porustobart, a Neoadjuvant Immuno-Oncology Therapy
September 9, 2026
·
5 min read
Press Releases
Summit Therapeutics and Lunit Announce Agreement to Apply AI-powered SCOPE IO Platform for Tumor Microenvironment Analysis in Immuno-Oncology Development
October 26, 2026
·
12 min read
Press Releases
Georgiamune and Menarini Group Enter Exclusive Global License and Collaboration Agreement for GIM-621, a First-in-Class Oral Immuno-Oncology Agent
October 22, 2026
·
4 min read
Press Releases
Cytospire Therapeutics Appoints Highly Experienced Immuno-Oncology Leader, Sumeet Ambarkhane, M.D., as Chief Medical Officer
September 8, 2026
·
3 min read
1 of 14,974
Next
